We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Updated: 1/1/1970
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)
Efficacy of Treating Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) on Ventricular Function, Exercise Capacity and Health Status
Status: Archived
Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)
Updated: 1/1/1970
Efficacy of Treating Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) on Ventricular Function, Exercise Capacity and Health Status
Status: Archived
Updated: 1/1/1970
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease
Status: Archived
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Updated: 1/1/1970
Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease
Status: Archived
Updated: 1/1/1970
T Wave Alternans in Hemodialysis
Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients
Status: Archived
T Wave Alternans in Hemodialysis
Updated: 1/1/1970
Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients
Status: Archived
Updated: 1/1/1970
Exercise to Treat Depression in Individuals With Coronary Heart Disease
Understanding the Prognostic Benefits of Exercise and Anti-depressant Therapy (UPBEAT)
Status: Archived
Exercise to Treat Depression in Individuals With Coronary Heart Disease
Updated: 1/1/1970
Understanding the Prognostic Benefits of Exercise and Anti-depressant Therapy (UPBEAT)
Status: Archived
Updated: 1/1/1970
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Status: Archived
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Updated: 1/1/1970
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Status: Archived
Updated: 1/1/1970
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Updated: 1/1/1970
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
Updated: 1/1/1970
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Updated: 1/1/1970
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
Updated: 1/1/1970
Single Comprehensive Ultrasound to Rule Out DVT in High-Risk Patients
Ultrasound-Sparing Strategy for Suspected DVT: A Prospective Clinical Cohort Study
Status: Archived
Single Comprehensive Ultrasound to Rule Out DVT in High-Risk Patients
Updated: 1/1/1970
Ultrasound-Sparing Strategy for Suspected DVT: A Prospective Clinical Cohort Study
Status: Archived
Updated: 1/1/1970
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Combined Rosiglitazone/Metformin (Avandamet®) vs. Placebo on Serological Outcomes in Non-Diabetic Patients With Stable Coronary Syndromes
Status: Archived
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
Updated: 1/1/1970
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Combined Rosiglitazone/Metformin (Avandamet®) vs. Placebo on Serological Outcomes in Non-Diabetic Patients With Stable Coronary Syndromes
Status: Archived
Updated: 1/1/1970
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
A Prospective, Randomized, Open-Label, Pilot Study To Compare The Effect On Carotid Atherosclerosis Of A Tacrolimus-Based Regimen With Conversion From A Tacrolimus- To A Sirolimus-Based Regimen At 3-4 Months Post-Transplant In De Novo Renal Transplant Recipients
Status: Archived
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
Updated: 1/1/1970
A Prospective, Randomized, Open-Label, Pilot Study To Compare The Effect On Carotid Atherosclerosis Of A Tacrolimus-Based Regimen With Conversion From A Tacrolimus- To A Sirolimus-Based Regimen At 3-4 Months Post-Transplant In De Novo Renal Transplant Recipients
Status: Archived
Updated: 1/1/1970
Interpersonal Psychotherapy for Depression in People With Heart Failure
Interpersonal Psychotherapy for Depression in Patients With Heart Failure
Status: Archived
Interpersonal Psychotherapy for Depression in People With Heart Failure
Updated: 1/1/1970
Interpersonal Psychotherapy for Depression in Patients With Heart Failure
Status: Archived
Updated: 1/1/1970
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)
Status: Archived
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
Updated: 1/1/1970
The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)
Status: Archived
Updated: 1/1/1970
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Status: Archived
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Updated: 1/1/1970
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Status: Archived
Updated: 1/1/1970
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease
Status: Archived
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
Updated: 1/1/1970
Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease
Status: Archived
Updated: 1/1/1970
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Updated: 1/1/1970
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Updated: 1/1/1970
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Updated: 1/1/1970
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Updated: 1/1/1970
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Updated: 1/1/1970
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Updated: 1/1/1970
Study of Carotid Occlusion and Neurocognition
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON)
Status: Archived
Study of Carotid Occlusion and Neurocognition
Updated: 1/1/1970
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON)
Status: Archived
Updated: 1/1/1970
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Status: Archived
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Updated: 1/1/1970
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Status: Archived
Updated: 1/1/1970
A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
A Randomized, Placebo-Controlled Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
Status: Archived
A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
Updated: 1/1/1970
A Randomized, Placebo-Controlled Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
Status: Archived
Updated: 1/1/1970
Chronic Administration of Subcutaneous Brain Natriuretic Peptide (SQ BNP) on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading
To Define in Human Preclinical Diastolic Dysfunction (PDD) the Actions of Chronic Administration of SQ BNP on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading - Protocol III
Status: Archived
Chronic Administration of Subcutaneous Brain Natriuretic Peptide (SQ BNP) on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading
Updated: 1/1/1970
To Define in Human Preclinical Diastolic Dysfunction (PDD) the Actions of Chronic Administration of SQ BNP on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading - Protocol III
Status: Archived
Updated: 1/1/1970
Human BNP (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function
To Define in Human Preclinical Systolic Dysfunction (PSD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal, and Humoral Function and on the Integrated Response to Acute Sodium Loading
Status: Archived
Human BNP (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function
Updated: 1/1/1970
To Define in Human Preclinical Systolic Dysfunction (PSD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal, and Humoral Function and on the Integrated Response to Acute Sodium Loading
Status: Archived
Updated: 1/1/1970
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
Abnormal 3-dimensional MRI Flow Patterns and Plasma Matrix Metalloproteinase Levels Predict Dilatation of Ascending Aorta in Adolescent Patients With Bicuspid Aortic Valve
Status: Archived
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
Updated: 1/1/1970
Abnormal 3-dimensional MRI Flow Patterns and Plasma Matrix Metalloproteinase Levels Predict Dilatation of Ascending Aorta in Adolescent Patients With Bicuspid Aortic Valve
Status: Archived
Updated: 1/1/1970
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
Updated: 1/1/1970
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
Updated: 1/1/1970
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
Updated: 1/1/1970
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
Updated: 1/1/1970
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Status: Archived
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Updated: 1/1/1970
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Status: Archived
Updated: 1/1/1970
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
Insights Into the Mechanism of Percutaneous Revascularization of Coronary Bifurcation Disease in the Drug-Eluting Stent Era. An Angiographic and Intravascular Ultrasound Study. The INSIGHT Trial
Status: Archived
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
Updated: 1/1/1970
Insights Into the Mechanism of Percutaneous Revascularization of Coronary Bifurcation Disease in the Drug-Eluting Stent Era. An Angiographic and Intravascular Ultrasound Study. The INSIGHT Trial
Status: Archived
Updated: 1/1/1970
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Updated: 1/1/1970
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Updated: 1/1/1970
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Updated: 1/1/1970
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Updated: 1/1/1970
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Updated: 1/1/1970
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Updated: 1/1/1970
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970